ARCHIVES

Vaccine Prevented Cervical Pre-Cancers, Non-Invasive Cancers In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Intramural Funding To Decrease, R01s Increase, Klausner Says

September 15, 1995

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

CT Screening for Lung Cancer Unproven; Limit Use to Trials, Chest Physicians Urge.

September 14, 2007

NCI Asks $135 Billion for FY 1981, Tells How New Money Would Be Spent

June 1, 1979

Eight Scientists Receive $800,000 From Milken

January 5, 1990

AACI Developing Suggestions Or New Cancer Control Grant Guidelines

July 20, 1979